An ongoing dialogue on HIV/AIDS, infectious diseases,
July 22nd, 2022
The Paperwork Demands for Academic Medical Teaching Are OUT OF CONTROL
Why all caps in the above title? It’s to call attention to a problem that’s getting worse each year in academic medicine, especially when it involves teaching or talks. The requirement to submit a veritable truckload of forms, documents, attestations, and summaries, all due months before the actual event. Let’s explore in more detail what this might […]
November 12th, 2021
Time to Simplify the COVID-19 Vaccine Policy — Authorize a Booster Dose for Anyone Who Wants One
At this point in the post-vaccine era of the pandemic, we all know people who have had COVID-19 despite being fully vaccinated. Patients, coworkers, family, friends. The reason these breakthroughs are so common is now obvious — our initial vaccine strategies did not provide durable protection against infection. And recognition of this fact prompted the FDA […]
May 25th, 2020
A Major Advance in Non-COVID-19 ID Research You Might Have Missed
One thing about the COVID-19 pandemic — other important non-COVID ID news gets crowded out. As a prime example, take HPTN 083, a major clinical trial in HIV prevention. The results are a big deal, and should have garnered more attention when they were released last week. This randomized, double-blind pre-exposure prophylaxis (PrEP) study compared long-acting injectable […]
December 15th, 2019
Should Oseltamivir Become an Over-the-Counter Drug?
News broke last week that oseltamivir — most commonly known by its clever (expired) brand name, Tamiflu — may be heading to pharmacies soon as an over-the-counter (OTC) drug, available without a prescription. After hearing this, I immediately thought of several reasons both supporting and opposing this change — an ideal question for a poll! Oseltamivir (brand […]
August 18th, 2019
Choosing the Top Research Papers in HIV Medicine — and Recalling the Joy of Working with a Great ID Fellow
Way back in 2008 — the year I started writing here — I drafted an exceedingly long post listing the top published papers in HIV medicine. Oh how I tortured myself over that thing. How to define “Top”? Most cited? Most clinically important? Most rigorously scientific? Best written? After a while, I just abandoned the monstrosity. It still […]
February 24th, 2019
Why Choose Infectious Diseases as a Medical Specialty? Here’s the Beginning of My Story, with Bonus Podcast
Forgive the autobiographical nature of this post, but here’s a recap on how I started down the the path to becoming an ID doctor. To begin, understand that my first year of medical school was rough going. In hindsight, this wasn’t surprising. After majoring in English during college (with a minor in the Harvard Lampoon to develop good […]
June 7th, 2018
What’s Your Favorite Off-Patent Antibiotic Brand Name?
Each time the FDA approves a new drug, they also approve a new brand name. The FDA and other regulators want something safe. They critically want to avoid names that sound or look similar to existing drugs, which could trigger medication errors. And names that imply an ingredient or an action not supported by clinical data […]
March 11th, 2018
Really Rapid Review — CROI 2018, Boston
The 25th Conference on Retroviruses and Opportunistic Infections (CROI) just wrapped up in warm, sunny Boston. Everyone in attendance took advantage of the fine March weather to get some much-needed sun, to feel the sand between their toes, to sip a tropical drink, and to hear the latest in HIV research. Well, the last part was true […]
September 25th, 2016
Is There a Hospitalist “Bounce-Back” to ID?
The New England Journal of Medicine recently published two outstanding pieces on hospitalists, and they had pretty much diametrically opposing perspectives. Both should be required reading for anyone practicing medicine, and indeed anyone who might know — or be — a patient in a U.S. hospital one day. In short, everyone. But since you may not have time, let me […]
August 27th, 2016
ID Cartoon Caption Contest #1 Winner — and a New Contest for the End of Summer
All blogs worth the price of admission have a sidebar, and this one is no exception. Critical components include (but are not limited to) the following: The Option to Subscribe — Go ahead, you know you want to. It’s right over there to the right. Just enter your email address and click subscribe — no username, password, or […]